EYLER CHARLES R 4/A
4/A · PUMA BIOTECHNOLOGY, INC. · Filed Aug 2, 2018
Insider Transaction Report
Form 4/AAmended
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2018-01-22$92.85/sh−669$62,117→ 28,027 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2017 to satisfy tax obligations in connection with the vesting of restricted stock units.
- [F2]This amended Form 4 is filed solely for the purpose of correcting an administrative error in column 4 reporting securities as acquired, instead of disposed of, as reported on the Form 4 filed January 24, 2018.